These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37421887)

  • 1. 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1.
    Finger V; Kucera T; Kafkova R; Muckova L; Dolezal R; Kubes J; Novak M; Prchal L; Lakatos L; Andrs M; Hympanova M; Marek J; Kufa M; Spiwok V; Soukup O; Mezeiova E; Janousek J; Nevosadova L; Benkova M; Kitson RRA; Kratky M; Bősze S; Mikusova K; Hartkoorn R; Roh J; Korabecny J
    Eur J Med Chem; 2023 Oct; 258():115611. PubMed ID: 37421887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
    Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
    PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening of Small Molecular Inhibitors against DprE1.
    Zhang G; Guo S; Cui H; Qi J
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the
    Ezquerra-Aznárez JM; Degiacomi G; Gašparovič H; Stelitano G; Sammartino JC; Korduláková J; Governa P; Manetti F; Pasca MR; Chiarelli LR; Ramón-García S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
    Panda M; Ramachandran S; Ramachandran V; Shirude PS; Humnabadkar V; Nagalapur K; Sharma S; Kaur P; Guptha S; Narayan A; Mahadevaswamy J; Ambady A; Hegde N; Rudrapatna SS; Hosagrahara VP; Sambandamurthy VK; Raichurkar A
    J Med Chem; 2014 Jun; 57(11):4761-71. PubMed ID: 24818517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches.
    Dash S; Rathi E; Kumar A; Chawla K; Kini SG
    Sci Rep; 2024 May; 14(1):11315. PubMed ID: 38760437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review.
    Dash S; Rathi E; Kumar A; Chawla K; Joseph A; Kini SG
    J Biomol Struct Dyn; 2024 Aug; 42(12):6472-6522. PubMed ID: 37395797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.
    Landge S; Mullick AB; Nagalapur K; Neres J; Subbulakshmi V; Murugan K; Ghosh A; Sadler C; Fellows MD; Humnabadkar V; Mahadevaswamy J; Vachaspati P; Sharma S; Kaur P; Mallya M; Rudrapatna S; Awasthy D; Sambandamurthy VK; Pojer F; Cole ST; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M; Ramachandran V
    Bioorg Med Chem; 2015 Dec; 23(24):7694-710. PubMed ID: 26643218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.
    Balabon O; Pitta E; Rogacki MK; Meiler E; Casanueva R; Guijarro L; Huss S; Lopez-Roman EM; Santos-Villarejo Á; Augustyns K; Ballell L; Aguirre DB; Bates RH; Cunningham F; Cacho M; Van der Veken P
    J Med Chem; 2020 May; 63(10):5367-5386. PubMed ID: 32342688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Chemical Inhibitor with a Novel Scaffold Targeting Decaprenylphosphoryl-β-D-Ribose Oxidase (DprE1).
    Matsunaga T; Monobe K; Aoki S
    Infect Disord Drug Targets; 2023; 23(5):e090323214508. PubMed ID: 36892121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes.
    Liu R; Lyu X; Batt SM; Hsu MH; Harbut MB; Vilchèze C; Cheng B; Ajayi K; Yang B; Yang Y; Guo H; Lin C; Gan F; Wang C; Franzblau SG; Jacobs WR; Besra GS; Johnson EF; Petrassi M; Chatterjee AK; Fütterer K; Wang F
    Angew Chem Int Ed Engl; 2017 Oct; 56(42):13011-13015. PubMed ID: 28815830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.
    Semelková L; Janošcová P; Fernandes C; Bouz G; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kuneš J; Doležal M; Zitko J
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28880230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.
    Wang P; Batt SM; Wang B; Fu L; Qin R; Lu Y; Li G; Besra GS; Huang H
    J Med Chem; 2021 May; 64(9):6241-6261. PubMed ID: 33852302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
    Naik M; Humnabadkar V; Tantry SJ; Panda M; Narayan A; Guptha S; Panduga V; Manjrekar P; Jena LK; Koushik K; Shanbhag G; Jatheendranath S; Manjunatha MR; Gorai G; Bathula C; Rudrapatna S; Achar V; Sharma S; Ambady A; Hegde N; Mahadevaswamy J; Kaur P; Sambandamurthy VK; Awasthy D; Narayan C; Ravishankar S; Madhavapeddi P; Reddy J; Prabhakar K; Saralaya R; Chatterji M; Whiteaker J; McLaughlin B; Chiarelli LR; Riccardi G; Pasca MR; Binda C; Neres J; Dhar N; Signorino-Gelo F; McKinney JD; Ramachandran V; Shandil R; Tommasi R; Iyer PS; Narayanan S; Hosagrahara V; Kavanagh S; Dinesh N; Ghorpade SR
    J Med Chem; 2014 Jun; 57(12):5419-34. PubMed ID: 24871036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DprE1--from the discovery to the promising tuberculosis drug target.
    Mikusová K; Makarov V; Neres J
    Curr Pharm Des; 2014; 20(27):4379-403. PubMed ID: 24245764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors.
    Whitehurst BC; Young RJ; Burley GA; Cacho M; Torres P; Vela-Gonzalez Del Peral L
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127192. PubMed ID: 32312582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
    Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
    Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.